BazEkon - Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie

BazEkon home page

Meny główne

Autor
Domaradzki Jan (Poznań University of Medical Sciences)
Tytuł
Geneticization and Biobanking
Źródło
Polish Sociological Review, 2019, nr 1, s. 103-117, bibliogr. 86 poz.
Słowa kluczowe
Banki, Biologia
Banks, Biology
Uwagi
summ., This paper was financed from the project Organization of Polish Biobanking Network within the Biobanking and Biomolecular Resources Research Infrastructure BBMRI-ERIC, supported by the Ministry of Science and Higher Education, Poland (DIR/WK/2017/01).
Abstrakt
While biobanks constitute an indispensable source of scientific data, they also generate many concerns related to the ethical, legal and social aspects of acquiring and storing of human biological material, particularly when it comes to the matters of privacy and confidentiality of data and commercialization of research results. It is important as social perception of biobanking may have a bigger impact on the donors than real scientific achievements, while negative images of biobanks may negatively influence the readiness to donate. This, in turn, may impede the functioning of biobanks. Thus, the aim of this paper is to describe the main social anxieties related to gathering and usage of human biological material. Beginning with the concept of geneticization, the paper will tackle the most important social concerns regarding biobanking: creation of a unique genohype, geneticization of diagnostics and identity, the risk of genetic discrimination and commercialization of genetics and gene patenting. (original abstract)
Dostępne w
Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie
Pełny tekst
Pokaż
Bibliografia
Pokaż
  1. Alper, J.S., and Beckwith, J.S. 1993. Genetic fatalism and social policy. The implications of behavior genetics research, Yale Journal of Biology and Medicine 66 (6): 511-524.
  2. Beskow, L.M., and Smolek, S.J. 2009. Prospective biorepository participants' perspectives on access to research results, Journal of Empirical Research on Human Research Ethics 4 (3): 99-111.
  3. Bledsoe, M.J. 2017. Ethical, legal and social issues of biobanking: past, present, and future, Biopreservation and Biobanking 15 (2): 142-147.
  4. Braun, B. 2007. Biopolitics and the molecularization of life, Cultural Geographies 14 (1): 6-28.
  5. Budin-Ljøsne, I., Harris, J.R., Kaye, J., Knoppers, B.M., Tassé, A.M., Bravo, E., Cambon-Thomsen, A., Eriksson, M., Ohm, K.K., Litton, J-E., Perola, M., Rial-Sebbag, E. 2012. ELSI challenges and strategies of national biobank infrastructures, Norsk Epidemiologi 21 (2): 155-160.
  6. Cadigan, R.J., Lassiter, D., Haldeman, K., Conlon I., Reavely, E., Henderson, G.E. 2013. Neglected ethical issues in biobank management: Results from a U.S. study, Life Sciences, Society and Policy 9: 1. https://doi.org/10.1186/2195-7819-9-1 [accessed 15.01.2018].
  7. Caulfield, T. 2004. Biotechnology and popular press: hype and the selling of science, Trends in Biotechnology 22 (7): 337-339.
  8. Caulfield, T., Gold, R., and C h o, M.K. 2000. Patenting human genetic material: refocusing the debate, Nature Reviews Genetics 1 (3): 227-231.
  9. Caulfield, T., and Bubela, T. 2004. Media representations of genetic discoveries: hype in the headlines?, Health Law Review 12 (2): 53-61.
  10. Caulfield, T., Bubela, T., and Murdoch, C.J. 2007. Myriad and the mass media: the covering of a gene patent controversy, Genetics in Medicine 9 (12): 850-855.
  11. Caulfield, T., Burningham, S., Joly, Y., Zubin, M., Shabani, M., Borry, P., Becker, A., Burgess, M., Calder, K., Critchley, Ch., Edwards, K., Fullerton, S.M., Gottweis, H., Hyde-Lay, R., Illes, J., Isasi, R., Kato, K., Kaye, J., Knoppers, B., Lynch, J., McGuire, A., Meslin, E., Nicol, D., O'Doherty, K., Ogbogu, U., Otlowski, M., Pullman, D., Ries, N., Scott, Ch., Sears, M., Wallace, H., and Zawati, M.H. 2014. A review of the key issues associated with the commercialization of biobanks, Journal of Law and the Biosciences 1 (1): 94-110.
  12. Caulfield, T., and Murdoch, B. 2017. Genes, cells, and biobanks: Yes, there's still a consent problem, PLoS Biology 15(7): e2002654. doi: 10.1371/journal.pbio.2002654.
  13. Clarke, A.E., Shim, J.K., Mamo, L., Fosket, J.R., and Fishman, J.R. 2003. Biomedicalization: technoscientific transformations of health, illness, and U.S. biomedicine, American Sociological Review 68 (2): 161-194.
  14. Cyranoski, D. 2018. First CRISPR babies: six questions that remain, Nature News December 1, 2018: https://www.nature.com/articles/d41586-018-07607-3 [20.01.2019].
  15. Dar-Nimrod, I., and Heine, S.J. 2011. Genetic essentialism: on the deceptive determinism of DNA, Psychological Bulletin 137 (5): 800-818.
  16. De Souza, Y.G., and Greenspan, J.S. 2013. Biobanking past, present and future: responsibilities and benefits, AIDS 27 (3): 303-312.
  17. Dickenson, D. 2009. Body Shopping. Converting Body Parts to Profit. Oxford: Oneworld.
  18. Domaradzki, J. 2017a. Medykalizacja a genetyzacja: ciągłość czy zmiana?, Przegląd Socjologiczny 66 (1): 9-31.
  19. Domaradzki, J. 2017b. Genetyka, esencjalizm i tożsamość, Studia Socjologiczne 1 (224): 1-32.
  20. Domaradzki, J. 2018. Społeczne konstruowanie genetyki. Reprezentacje biotechnologii w polskim czasopiśmiennictwie opiniotwórczym. Poznań: Wydawnictwo Naukowe Uniwersytetu Medycznego w Poznaniu.
  21. Everett, M. 2003. The social life of genes: privacy, property and the new genetics, Social Science and Medicine 56 (1): 53-65.
  22. Evers, K., Forsberg, J., and Hansson, M. 2012. Commercialization of biobanks, Biopreservation and Biobanking 10 (1): 45-47.
  23. Feldman, E.A. 2012. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine, Journal of General Internal Medicine 27 (6): 743-746.
  24. Feldman, E.A., and Darnell, Ch. 2013. Health insurance, employment, and the human genome: genetic discrimination and biobanks in the United States, in: G. Pascuzzi, U. Izzo, and M. Macilotti (ed.), Comparative Issues in the Governance of Research Biobanks: Property, Privacy, Intellectual Property, and the Role of Technology. Berlin: Springer Science & Business Media, pp. 63-76.
  25. Fong, M., Braun, K.L., and Chang, R. Mei-Ling. 2006. Native Hawaiian preferences for informed consent and disclosure of results from genetic research, Journal of Cancer Education 21 (suppl 1): S47-S52.
  26. Frank, K.M., Hogarth, D.K., Miller, J.L., Mandal, S., Mease, P.J., Samulski, R.J., Weisgerber, G.A., and Hart, J. 2009. Investigation of the cause of death in a gene-therapy trial, New England Journal of Medicine 361 (2): 161-169.
  27. Gaskell , G., Gottweis, H., Starkbaum, J., Gerber, M.M., Broerse, J., Gottweis, U., Hobbs, A., Ilpo, H., Paschou, M., Snell, K., and Soulier, A. 2013. Publics and biobanks: Pan European diversity and the Challenge of Responsible Innovation, European Journal of Human Genetics 21 (1): 14-20.
  28. Geller, G., Bernhardt, B.A., and Holtzman, N.A. 2002. The media and public reaction to genetic research, Journal of the American Medical Association 287 (6): 773.
  29. Goddard, K.A.B., Smith, K.S., Chen, Ch., Mc Mullen, C., and Johnson, Ch. 2009. Biobank recruitment: motivations for nonparticipation, Biopreservation and Biobanking 7 (2): 119-121.
  30. Goodson, M.L., and Vernon, B.G. 2004. A study of public opinion on the use of tissue samples from living subjects for clinical research, Journal of Clinical Pathology 57 (2): 135-138.
  31. Goodman, A.H. 1999. Epistemology of complex traits in an age of geneticization, Current Psychology of Cognition 18 (2): 176-181.
  32. Hallowell, N. 1999. Doing the Right Thing: Genetic Risk and Responsibility, Sociology of Health and Illness 21 (5): 597-621.
  33. Hedgecoe, A. 1997. Reconstructing geneticization: a research manifesto, Health Law Journal 7: 5-18.
  34. Hedgecoe, A. 2001. Schizophrenia and the narrative of enlightened geneticization, Social Studies of Science 31 (6): 875-911.
  35. Hedgecoe, A. 2002. Reinventing diabetes: classification, division and the geneticization of disease, New Genetics and Society 21 (1): 7-27.
  36. Heredia, N.I., Krasny, S., Strong, L.L., Von Hatten, L., Nguyen, L., Reininger, B.M., Mc-Neill, L.H., and Fernández, M.E. 2017. Community perceptions of biobanking participation: a qualitative study among Mexican-Americans in three Texas cities, Public Health Genomics 20 (1): 46-57.
  37. Hewitt, R.E. 2011. Biobanking: the foundation of personalized medicine, Current Opinion in Oncology 23 (1): 112-119.
  38. Hoeyer, K. 2010. Donors perceptions of consent to and feedback from biobank research: time to acknowledge diversity?, Public Health Genomics 13 (6): 345-352.
  39. Holtz, T.H., Holmes, S., Stonington, S., and Eisenberg, L. 2006. Health is still social: contemporary examples in the age of the genome, PLoS Medicine 3 (10): e419.
  40. Holtzman, N. 1999. Are genetic tests adequately regulated?, Science 286 (4539): 409.
  41. Kamenova, K., Reshef, A., and Caulfield, T. 2014. Angelina Jolie's faulty gene: newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United Kingdom, Genetics in Medicine 16 (7): 522-528.
  42. Kawłatow, G. 2012. Patentowanie ludzkich genów, Diametros 32: 77-90.
  43. Klitzman, R. 2009. Am I my genes?: Questions of identity among individuals confronting genetic disease, Genetics in Medicine 11 (12): 880-889.
  44. Klitzman, R. 2010. Views of discrimination among individuals confronting genetic disease, Journal of Genetic Counseling 19 (1): 68-83.
  45. Kozera, Ł., Strapagiel, D., Gleńska-Olender, J., Chrościcka, A., Ferdyn, K., Skokowski, J., Kalinowski, L., Pawlikowski, J., Marciniak, B., Pasterk, M., Matera-Witkiewicz, A., Lewandowska-Szumieł, M., Piast, M., and Witoń, M. 2018. Biobankowanie ludzkiego materiału biologicznego dla celów naukowych w Polsce i w Europie, Studia Iuridica 73: 12-28.
  46. Krajewska-Kułak, E., Kułak, W., Van Damme-Ostapowicz, K., Rozwadowska, E., and Lewko, J. 2011. Students opinions on DNA banking. Preliminary report, Progress in Health Sciences 1 (2): 102-105.
  47. Lemke, T. 2004. Disposition and determinism-genetic diagnostics in risk society, Sociological Review 52 (4): 550-566.
  48. Lemke, A.A., Wolf, W.A., Hebert-Beirne J., and Smith, M.E. 2010. Public and biobank participant attitudes toward genetic research participation and data sharing, Public Health Genomics 13 (6): 368-377.
  49. Lewis, C., Clotworthy, M., Hilton, S., Magee, C., Robertson, M.J., Stubbins, L.J., and Corfield, J. 2013. Public views on the donation and use of human biological samples in biomedical research: a mixed methods study, BMJ Open 3 (8): e003056. doi:10.1136/bmjopen-2013-003056.
  50. Lippman, A. 1991. Prenatal genetic testing and screening: constructing needs and reinforcing inequities, American Journal of Law and Medicine 17 (1-2): 15-50.
  51. Lippman, A. 1999. The Human Genome Project: perilous promises?, Medicine, Health Care and Philosophy 2 (1): 47-49.
  52. Łuków, P., and Żekanowski, C. 2005. Pojęcie genu i genocentryczny paradygmat biologii, Przegląd Filozoficzny 53 (1): 85-105.
  53. Marks, J. 2006. Human Genome Diversity Project (HGDP): impact on indigenous communities, in: A. Clarke and F. Ticehurst (ed.), Living with the genome. Ethical and social aspects of human genetics. New York: Palgrave MacMillan, pp. 49-55.
  54. Master, Z., Claudio, J.O., Rachul, Ch., Wang, J.C.Y., Minden, M.D., and Caulfield, T. 2013. Cancer patient perceptions on the ethical and legal issues related to biobanking, BMC Medical Genomics 6: 8.
  55. McGuire, A.L., Hamilton, J.A., Lunstroth, R., McCullough, L.B., and Goldman, A. 2008. DNA data sharing: research participants' perspectives, Genetics in Medicine 10 (1): 46-53.
  56. Melzer, D., and Zimmern, R. 2002. Genetics and medicalisation: genetics could drive a new wave of medicalization if genetic tests are accepted without appropriate clinical evaluation, British Medical Journal 324 (7342): 863-894.
  57. Musunuru, K. 2017. The hope and hype of CRISPR-Cas9 genome editing: A review, JAMA Cardiology 2 (8): 914-919.
  58. Novas, C. 2006. The political economy of hope: patients' organizations, science and biovalue, Biosocieties 1 (3): 289-305.
  59. Novas, C., and Rose, Nokolas. 2000. Genetic risk and the birth of the somatic individual, Economy and Society 29 (4): 485-513.
  60. Ogbogu, U., Toews, M., Ollenberger, A., Borry, P., Nobile, H., Bergmann, M., and Caulfield, T. 2014. Newspaper coverage of biobanks, Peer Jornal 2: e500.
  61. Pawlikowski, J. 2013. Biobankowanie ludzkiego materiału biologicznego dla celów naukowych - aspekty organizacyjne, etyczne, prawne i społeczne. Lublin: Wydawnictwo Uniwersytetu Medycznego w Lublinie.
  62. Pawlikowski, Jakub, Sak, Jarosław, and Marczewski, Krzysztof. 2009. The analysis of the ethical, organizational and legal aspects of Polish biobanks activity, European Journal of Public Health 20 (6): 707-710.
  63. Pawlikowski, J., Sak, J., and Marczewski, K. 2011. Biobank research and ethics: the problem of informed consent in Polish biobanks, Archives of Medical Science 7 (5): 896-901.
  64. Porteri, C., Pasqualetti, P., Togni, E., and Parker, M. 2014. Public's attitudes on participation in a biobank for research: an Italian survey, BMC Medical Ethics 15 (1): 81. doi:10.1186/1472-6939-1581.
  65. Phelan, J.C. 2005. Geneticization of deviant behavior and consequences for stigma: the case of mental illness, Journal of Health and Social Behavior 46 (4): 307-322.
  66. Rabinow, P. 1996. Artificiality and enlightenment: from sociobiology to biosociality, in: P. Rabinow (ed.), Essays on the Anthropology of Reason. Princeton: Princeton University Press, pp. 91-111.
  67. Rose, N. 2007. The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-first Century. Princeton, NJ: Princeton University Press.
  68. Rose, N., and Novas, C. 2004. Biological citizenship, in: A. Ong, S.J. Collier (eds.), Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. Oxford: Blackwell Publishing, pp. 439-463.
  69. Rose, S. 1995. The rise of neurogenetic determinism, Nature 373 (6513): 380-382.
  70. Sak, J., Pawlikowski, J., Goniewicz, M., Witt, M. 2012. Population biobanking in selected European countries and proposed model for a Polish national DNA bank, Journal of Applied Genetics 53 (2): 159-165.
  71. Saulnier, K., and Joly, Y. 2016. Locating biobanks in the Canadian privacy maze, Journal of Law Medicine and Ethics 44 (1): 7-19.
  72. Schwartz, M.D., Rothenberg, Karen, Joseph, Linda, Benkendorf, Judith, and Lerman, Caryn. 2001. Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population, American Journal of Medical Genetics 98 (4): 336-342.
  73. Shabani, M., Bezuidenhout, L., and Borry, P. 2014. Attitudes of research participants and the general public towards genomic data sharing: a systematic literature review, Expert Review of Molecular Diagnostics 14 (8): 1053-1065.
  74. Sibbald, B. 2001. Death but one unintended consequence of gene-therapy trial, Canadian Medical Association Journal 164 (11): 1612.
  75. Simon, Ch.M., L'Heureux, Jamie, Murray, Jeffrey C., Winokur, Patricia, Weiner, George, Newbury, Elizabeth, Shinkunas, Laura, and Zimmerman, Bridget. 2011. Active choice but not too active: public perspectives on biobank consent models, Genetics in Medicine 13 (9): 821-831.
  76. Soniewicka, M. 2018. Selekcja genetyczna w prokreacji medycznie wspomaganej. Etyczne i prawne kryteria. Warszawa: Wolters Kluwer.
  77. Spruill, I.J., Gibbs, Y.C., Laken, M., and Williams, T. 2014. Perceptions toward establishing a biobank and clinical data warehouse: voices from the community, Clinical Nursing Studies 2 (3): 97-106.
  78. Stanek, J. 2016. Patentowanie genów ludzkich. Warszawa: Wolters Kluwer.
  79. Stempsey, W.E. 2006. The geneticization of diagnostics, Medicine, Health Care and Philosophy 9 (2): 193-200.
  80. Strohman, R.C. 2003. Genetic determinism as a failing paradigm in biology and medicine. Implications for health and wellness, Journal of Social Work Education 39 (2): 169-191.
  81. Tambor, E.S., Bernhardt, B.A., Rodgers, J., Holtzman, N.A., and Geller, G. 2002. Mapping the human genome: an assessment of media coverage and public reaction, Genetics in Medicine 4 (1): 31-36.
  82. ten Have, H. 2001. Genetics and culture: the geneticization thesis, Medicine, Health Care and Philosophy 4 (3): 295-304.
  83. Thurtle-Schmidt, D.M., and Lo, T.W. 2018. Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates, Biochemistry and Molecular Biology Education 46 (2): 195-205.
  84. Wauters, A., and Van Hoyweghen, I., 2016. Global trends on fears and concerns of genetic discrimination: a systematic literature review, Journal of Human Genetics 61 (4): 275-282.
  85. Williams, J.K., Ayers, L., Specht, J.K., Sparbel, K.J., and Klimek, M.L. 2009. Caregiving by teens for family members with Huntington disease, Journal of Family Nursing 15 (3): 273-294.
  86. Witoń, M., Strapagiel, D., Gleńska-Olender J., Chróścicka, A., Ferdyn, K., Skokowski, J., Kalinowski, L., Pawlikowski, J., Marciniak, B., Pasterk, M., Matera-Witkiewicz, A., Kozera, Ł. 2017. Organization of BBMRI.pl: The Polish Biobanking Network, Biopreservation and Biobanking 15 (3): 264-269.
Cytowane przez
Pokaż
ISSN
1231-1413
Język
eng
URI / DOI
http://dx.doi.org/10.26412/psr205.07
Udostępnij na Facebooku Udostępnij na Twitterze Udostępnij na Google+ Udostępnij na Pinterest Udostępnij na LinkedIn Wyślij znajomemu